Skip to main content

Year: 2021

Ranger Oil Increases Oil Sales Guidance for Fourth Quarter 2021

— Leaves Capex Guidance Unchanged —— Updates Hedge Positions — HOUSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) — Ranger Oil Corporation (“Ranger” or the “Company”) (Nasdaq: ROCC) today announced an increase in the Company’s oil sales guidance for the fourth quarter 2021 and updated its current hedge position. Darrin Henke, President and Chief Executive Officer of Ranger commented, “I am very pleased to announce that, due to the observed outperformance of existing wells, faster cycle times and less anticipated downtime, we now expect our fourth quarter sales volumes to be considerably higher than initially anticipated.  As a result, we are positively revising as well as narrowing our guidance of anticipated sales volumes for the fourth quarter from a range of 25,700 – 27,700 barrels...

Continue reading

Diversey completes acquisition of Birko Corporation and Chad Equipment LLC

Acquisition Highlights:Enhances Diversey’s scale and competitive position in the global food and beverage market, making Diversey a leading player in North America and in every major market around the world Transforms Diversey’s North America sales and technical service footprint, which is a top strategic priority Enables further market expansion of a broader cleaning and equipment portfolio, including additional opportunity to cross-sell water treatment and accelerate growth with strategic global customers Expands manufacturing capacity across the U.S., giving Diversey greater strategic control of the supply chain to improve fulfillment service to customers and increase efficiency throughout the plant networkFORT MILL, S.C., Dec. 06, 2021 (GLOBE NEWSWIRE) —  Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene,...

Continue reading

GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates

DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the third quarter ended September 30, 2021 and gave updates on its business. Third Quarter 2021 Financial Results Cash position Cash was $280.7 million as of September 30, 2021, compared to $5.9 million as of December 31, 2020. Research and development expenses R&D expenses were $2.6 million for the quarter ended September 30, 2021, compared to $55 thousand for the same quarter in 2020. The increase was primarily due to increased activities relating to our technical developments and clinical trials and increases in employee expenses to support these activities. General and administrative...

Continue reading

LiDAR Market to Rise at 22.7% CAGR till 2026; Uses in Seismic Monitoring Will Create Several Growth Opportunities, says Fortune Business Insights™

Companies in the LiDAR Market are Beijing SureStar Technology Co.Ltd., FARO Technologies, Inc., HEXAGON, Leica Geosystems, RIEGL Laser Measurement Systems GmbH, SICK AG, Teledyne Technologies, Trimble Inc., Velodyne Lidar, Inc., YellowScan and others Pune, India, Dec. 06, 2021 (GLOBE NEWSWIRE) — The global LiDAR market size is projected to reach USD 6.71 billion by 2026. Driven by increasing investments in the development of newer products, the market will rise considerably in the coming years. According to a report published by Fortune Business Insights, titled “Light Detection and Ranging (LiDAR) Market Size, Share & Industry Analysis, By Type (Mechanical and Solid-state), By Deployment (Ground-based and Airborne), By Application (Mapping and Cartography, ADAS (Advanced driver-assistance System), Surveillance, Environment,...

Continue reading

Aziyo Biologics Announces $14.0 Million Private Placement

SILVER SPRING, Md., Dec. 06, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (the “Company”) today announced that it has entered into a definitive agreement to sell securities in a private placement that is expected to result in gross proceeds to the Company of approximately $14.0 million, before deducting offering expenses. Certain accredited investors have agreed to purchase an aggregate of 2,122,637 shares of the Company’s Class A common stock and 1,179,244 shares of the Company’s Class B common stock, in each case, at a price of $4.24 per share. The closing of the offering is subject to certain conditions and is expected to occur on December 8, 2021. The offer and sale of the foregoing securities are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended...

Continue reading

WISDOMTREE S&P 500 VIX SHORT-TERM FUTURES 2.25X DAILY LEVERAGED SECURITIES ISIN: IE00BLRPRH06

6 December 2021 LSE Code: VIXL WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE S&P 500 VIX SHORT-TERM FUTURES 2.25X DAILY LEVERAGED SECURITIES ISIN: IE00BLRPRH06 RESULTS OF MEETING OF THE ETP SECURITYHOLDERS WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) wishes to announce that the Extraordinary Resolution regarding the reduction in the principal amount of the WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged Securities (the “Affected Securities”) from USD 1.05566 to USD 0.105566, as set out in a notice to holders of the Affected Securities dated 21 October 2021, was not passed at an adjourned meeting of the holders of the Affected Securities held at 11am on 6 December 2021. As a result, the principal amount of the...

Continue reading

Company to Present at Sequire Clean Tech & EV Conference.

Mississauga, Dec. 06, 2021 (GLOBE NEWSWIRE) — Worksport Ltd (Nasdaq-CM: WKSP) (the “Company”) announced today that it will be presenting virtually at the upcoming Sequire Clean Tech & EV Conference on Monday, December 6th, at 8:00 AM ET. Steven Rossi, Worksport CEO, will be giving the presentation. “I am very happy to be presenting at the Sequire Clean Tech & EV Conference. This is a great opportunity to share some updates on what’s left to come in 2021 and what’s coming up in 2022. I am very excited at everything that is about to take place and we hope that everyone sticks around for what’s to come”, says Worksport CEO, Steven Rossi. Event: Worksport Ltd. Presentation at the Sequire Clean Tech & EV ConferenceDate: Monday, December 6th, 2021Time: 8:00 AM Eastern Time Register to watch the presentation HERE. Investors...

Continue reading

Merus Presents Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today released clinical data on MCLA-145 from the phase 1 trial in patients with solid tumors at the ESMO Immuno-Oncology Congress 2021 being held virtually. “We are encouraged by the progress we are making with MCLA-145,” said Dr. Andrew Joe, Chief Medical Officer. “Patients have been treated at 8 dose levels with preliminary evidence of antitumor activity observed, as we continue to explore MCLA-145 as monotherapy.” MCLA-145 The reported data are from the phase 1 open-label, multicenter dose escalation study, of bispecific antibody MCLA-145 in patients with...

Continue reading

ABQQ Announced Launches NFT Movie and Music Marketplace

NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) — AB International Group Corp. (OTCQB: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces launchings its STAREASTnet NFT Movies and Music Marketplace (NFT MMM). The NFT MMM app available download at Google Play at https://play.google.com/store/apps/details?id=yz.nft.movie ABQQ rolled out two film NFTs “A Picture” and Sitcom “I Wanna Feel You Never Changed” at NFT MMM, two films had been global market released on video streaming website www.abqq.tv. Buyers get a blockchain-stored package of advantage when purchasing an ABQQ NFT for a film, including:ownership of the movie file exclusive perpetual worldwide commercial and profit dividend share revenue generated by license fee through multi streaming, to view the film on ABQQ.tv a copy of the sale and...

Continue reading

Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer

BEDMINSTER, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (LNC) platform delivery technology, today announced the appointment of Thomas Hoover to the newly created position of Chief Business Officer. Mr. Hoover’s role will include business and corporate development, strategic planning, licensing, and alliance management. “We are excited to have Thomas join our executive leadership team in this critical role during this transformational time for our Company,” commented Jerome D. Jabbour, Chief Executive Officer of Matinas. “Thomas’ extensive experience in leading commercial and corporate development functions will be invaluable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.